- Home
- KORE vs MRSN Comparison
KORE vs MRSN Comparison
Compare KORE & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KORE
- MRSN
- Stock Information
- Founded
- KORE 2003
- MRSN 2001
- Country
- KORE United States
- MRSN United States
- Employees
- KORE N/A
- MRSN N/A
- Industry
- KORE Telecommunications Equipment
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- KORE Consumer Discretionary
- MRSN Health Care
- Exchange
- KORE Nasdaq
- MRSN Nasdaq
- Market Cap
- KORE 44.4M
- MRSN 36.4M
- IPO Year
- KORE N/A
- MRSN 2017
- Fundamental
- Price
- KORE $2.42
- MRSN $0.35
- Analyst Decision
- KORE Hold
- MRSN Buy
- Analyst Count
- KORE 1
- MRSN 3
- Target Price
- KORE $2.50
- MRSN $4.00
- AVG Volume (30 Days)
- KORE 13.0K
- MRSN 3.1M
- Earning Date
- KORE 05-14-2025
- MRSN 05-08-2025
- Dividend Yield
- KORE N/A
- MRSN N/A
- EPS Growth
- KORE N/A
- MRSN N/A
- EPS
- KORE N/A
- MRSN N/A
- Revenue
- KORE $285,229,000.00
- MRSN $40,497,000.00
- Revenue This Year
- KORE $3.89
- MRSN N/A
- Revenue Next Year
- KORE $5.35
- MRSN N/A
- P/E Ratio
- KORE N/A
- MRSN N/A
- Revenue Growth
- KORE 7.01
- MRSN 9.88
- 52 Week Low
- KORE $1.10
- MRSN $0.26
- 52 Week High
- KORE $4.88
- MRSN $3.83
- Technical
- Relative Strength Index (RSI)
- KORE 50.01
- MRSN 44.90
- Support Level
- KORE $2.20
- MRSN $0.31
- Resistance Level
- KORE $2.55
- MRSN $0.40
- Average True Range (ATR)
- KORE 0.18
- MRSN 0.05
- MACD
- KORE -0.00
- MRSN 0.01
- Stochastic Oscillator
- KORE 62.75
- MRSN 68.09
About KORE KORE Group Holdings Inc.
Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates a majority of its revenue from the United States and the rest from other countries.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.